429 related articles for article (PubMed ID: 32028732)
1. Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective.
Azad MA; Olawuni D; Kimbell G; Badruddoza AZM; Hossain MS; Sultana T
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32028732
[TBL] [Abstract][Full Text] [Related]
2. Coupling hot melt extrusion and fused deposition modeling: Critical properties for successful performance.
Bandari S; Nyavanandi D; Dumpa N; Repka MA
Adv Drug Deliv Rev; 2021 May; 172():52-63. PubMed ID: 33571550
[TBL] [Abstract][Full Text] [Related]
3. Roadmap to 3D-Printed Oral Pharmaceutical Dosage Forms: Feedstock Filament Properties and Characterization for Fused Deposition Modeling.
Aho J; Bøtker JP; Genina N; Edinger M; Arnfast L; Rantanen J
J Pharm Sci; 2019 Jan; 108(1):26-35. PubMed ID: 30445005
[TBL] [Abstract][Full Text] [Related]
4. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
5. Hot Melt Extrusion and its Application in 3D Printing of Pharmaceuticals.
Deshkar S; Rathi M; Zambad S; Gandhi K
Curr Drug Deliv; 2021; 18(4):387-407. PubMed ID: 33176646
[TBL] [Abstract][Full Text] [Related]
6. Quality of FDM 3D Printed Medicines for Pediatrics: Considerations for Formulation Development, Filament Extrusion, Printing Process and Printer Design.
Quodbach J; Bogdahn M; Breitkreutz J; Chamberlain R; Eggenreich K; Elia AG; Gottschalk N; Gunkel-Grabole G; Hoffmann L; Kapote D; Kipping T; Klinken S; Loose F; Marquetant T; Windolf H; Geißler S; Spitz T
Ther Innov Regul Sci; 2022 Nov; 56(6):910-928. PubMed ID: 34826120
[TBL] [Abstract][Full Text] [Related]
7. 3D Printing Technology as a Promising Tool to Design Nanomedicine-Based Solid Dosage Forms: Contemporary Research and Future Scope.
Ahmad J; Garg A; Mustafa G; Mohammed AA; Ahmad MZ
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242690
[TBL] [Abstract][Full Text] [Related]
8. Polyvinyl Alcohol, a Versatile Excipient for Pharmaceutical 3D Printing.
Couți N; Porfire A; Iovanov R; Crișan AG; Iurian S; Casian T; Tomuță I
Polymers (Basel); 2024 Feb; 16(4):. PubMed ID: 38399895
[TBL] [Abstract][Full Text] [Related]
9. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
10. Hot-melt extruded filaments based on pharmaceutical grade polymers for 3D printing by fused deposition modeling.
Melocchi A; Parietti F; Maroni A; Foppoli A; Gazzaniga A; Zema L
Int J Pharm; 2016 Jul; 509(1-2):255-263. PubMed ID: 27215535
[TBL] [Abstract][Full Text] [Related]
11. Challenges, current status and emerging strategies in the development of rapidly dissolving FDM 3D-printed tablets: An overview and commentary.
Serajuddin ATM
ADMET DMPK; 2023; 11(1):33-55. PubMed ID: 36778904
[TBL] [Abstract][Full Text] [Related]
12. Rheology as a tool for evaluation of melt processability of innovative dosage forms.
Aho J; Boetker JP; Baldursdottir S; Rantanen J
Int J Pharm; 2015 Oct; 494(2):623-642. PubMed ID: 25666026
[TBL] [Abstract][Full Text] [Related]
13. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
14. Veering to a Continuous Platform of Fused Deposition Modeling Based 3D Printing for Pharmaceutical Dosage Forms: Understanding the Effect of Layer Orientation on Formulation Performance.
Kulkarni VR; Chakka J; Alkadi F; Maniruzzaman M
Pharmaceutics; 2023 Apr; 15(5):. PubMed ID: 37242565
[TBL] [Abstract][Full Text] [Related]
15. Advanced Pharmaceutical Applications of Hot-Melt Extrusion Coupled with Fused Deposition Modelling (FDM) 3D Printing for Personalised Drug Delivery.
Tan DK; Maniruzzaman M; Nokhodchi A
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30356002
[TBL] [Abstract][Full Text] [Related]
16. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
17. 3D printing for drug manufacturing: A perspective on the future of pharmaceuticals.
Lepowsky E; Tasoglu S
Int J Bioprint; 2018; 4(1):119. PubMed ID: 33102905
[TBL] [Abstract][Full Text] [Related]
18. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
19. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems.
Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
Pharm Res; 2018 Nov; 36(1):4. PubMed ID: 30406349
[TBL] [Abstract][Full Text] [Related]
20. Polyvinyl Alcohol-Based 3D Printed Tablets: Novel Insight into the Influence of Polymer Particle Size on Filament Preparation and Drug Release Performance.
Crișan AG; Porfire A; Ambrus R; Katona G; Rus LM; Porav AS; Ilyés K; Tomuță I
Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34062744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
